Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Dual color fluorescence in situ hybridization (FISH) assays for detecting Mycobacterium tuberculosis and Mycobacterium avium complexes and related pathogens in cultures.

Shah J, Weltman H, Narciso P, Murphy C, Poruri A, Baliga S, Sharon L, York M, Cunningham G, Miller S, Caviedes L, Gilman R, Desmond E, Ramasamy R.

PLoS One. 2017 Apr 11;12(4):e0174989. doi: 10.1371/journal.pone.0174989. eCollection 2017.

2.

Pulmonary tuberculosis followed by sarcoidosis in an HIV-infected patient: A case report and a simplified diagnostic flowchart for diagnosis and treatment of sarcoidosis.

Mencarini P, Bellagamba R, Oliva A, Ghirga P, Giancola ML, Corpolongo A, Ascoli Bartoli T, De Nardo P, Baiocchini A, Del Nonno F, Narciso P, Nicastri E.

Respir Med Case Rep. 2016 Sep 28;19:150-154. eCollection 2016.

3.

Elimination of Mother-To-Child Transmission of HIV Infection: The Drug Resource Enhancement against AIDS and Malnutrition Model.

Liotta G, Marazzi MC, Mothibi KE, Zimba I, Amangoua EE, Bonje EK, Bossiky BN, Robinson PA, Scarcella P, Musokotwane K, Palombi L, Germano P, Narciso P, de Luca A, Alumando E, Mamary SH, Magid NA, Guidotti G, Mancinelli S, Orlando S, Peroni M, Buonomo E, Nielsen-Saines K.

Int J Environ Res Public Health. 2015 Oct 21;12(10):13224-39. doi: 10.3390/ijerph121013224. Review.

4.

Varicella zoster virus infection presenting as isolated diplopia: a case report.

Pisapia R, Rianda A, Mariano A, Testa A, Galgani S, Vincenzi L, Abdeddaim A, Oliva A, Narciso P.

BMC Infect Dis. 2013 Mar 15;13:138. doi: 10.1186/1471-2334-13-138.

5.

Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine.

Corpolongo A, De Nardo P, Ghirga P, Gentilotti E, Bellagamba R, Tommasi C, Paglia MG, Nicastri E, Narciso P.

Malar J. 2012 Mar 27;11:91. doi: 10.1186/1475-2875-11-91.

6.

Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy.

Santoro MM, Alteri C, Ronga L, Flandre P, Fabeni L, Mercurio F, D'Arrigo R, Gori C, Palamara G, Bertoli A, Forbici F, Salpini R, Boumis E, Tozzi V, Visco-Comandini U, Zaccarelli M, Van Houtte M, Pattery T, Narciso P, Antinori A, Ceccherini-Silberstein F, Perno CF.

AIDS Res Hum Retroviruses. 2012 Oct;28(10):1285-93. Epub 2012 Apr 18.

7.

Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz.

Focà E, Motta D, Borderi M, Gotti D, Albini L, Calabresi A, Izzo I, Bellagamba R, Narciso P, Sighinolfi L, Clò A, Gibellini D, Quiros-Roldan E, Brianese N, Cesana BM, Re MC, Torti C.

BMC Infect Dis. 2012 Feb 14;12:38. doi: 10.1186/1471-2334-12-38.

8.

Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing.

Armenia D, Vandenbroucke I, Fabeni L, Van Marck H, Cento V, D'Arrigo R, Van Wesenbeeck L, Scopelliti F, Micheli V, Bruzzone B, Lo Caputo S, Aerssens J, Rizzardini G, Tozzi V, Narciso P, Antinori A, Stuyver L, Perno CF, Ceccherini-Silberstein F.

J Infect Dis. 2012 Feb 15;205(4):557-67. doi: 10.1093/infdis/jir821. Epub 2012 Jan 11.

9.

Total hip replacement infected with Mycobacterium tuberculosis complicated by Addison disease and psoas muscle abscess: a case report.

De Nardo P, Corpolongo A, Conte A, Gentilotti E, Narciso P.

J Med Case Rep. 2012 Jan 10;6:3. doi: 10.1186/1752-1947-6-3.

10.

Cost of surgical intervention for reconstructive therapy of HIV-associated facial lipoatrophy.

Massella M, Ivanovic J, Bellagamba R, De Vita R, Fracasso L, Tozzi V, Fragola V, Rizzica M, Narciso P.

Patient Prefer Adherence. 2011;5:223-8. doi: 10.2147/PPA.S16819. Epub 2011 May 17.

11.

Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis.

Tommasi C, Bellagamba R, Tempestilli M, D'Avolio A, Gallo AL, Ivanovic J, Nicastri E, Pucillo LP, Narciso P.

Malar J. 2011 May 21;10:141. doi: 10.1186/1475-2875-10-141.

12.

A case of pulmonary tuberculosis presenting as diffuse alveolar haemorrhage: is there a role for anticardiolipin antibodies?

Marruchella A, Corpolongo A, Tommasi C, Lauria FN, Narciso P.

BMC Infect Dis. 2010 Feb 20;10:33. doi: 10.1186/1471-2334-10-33.

13.

T20QoL: an observational multicenter cohort study to evaluate the quality of life in HIV-patients treated with enfuvirtide (ENF, T-20) in combination with an optimized background therapy.

Bucciardini R, Massella M, Corpolongo A, Narciso P, Fragola V, Mirra M, Donnini S, Viganò O, Costarelli S, Tozzi V.

Biologics. 2008 Sep;2(3):577-81.

14.

Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations.

Rozera G, Abbate I, Bruselles A, Vlassi C, D'Offizi G, Narciso P, Chillemi G, Prosperi M, Ippolito G, Capobianchi MR.

Retrovirology. 2009 Feb 12;6:15. doi: 10.1186/1742-4690-6-15.

15.

Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev.

Svicher V, Alteri C, D'Arrigo R, Laganà A, Trignetti M, Lo Caputo S, Callegaro AP, Maggiolo F, Mazzotta F, Ferro A, Dimonte S, Aquaro S, di Perri G, Bonora S, Tommasi C, Trotta MP, Narciso P, Antinori A, Perno CF, Ceccherini-Silberstein F.

Antimicrob Agents Chemother. 2009 Jul;53(7):2816-23. doi: 10.1128/AAC.01067-08. Epub 2009 Jan 5.

16.

Diagnostic difficulties of Lactobacillus casei bacteraemia in immunocompetent patients: a case report.

Tommasi C, Equitani F, Masala M, Ballardini M, Favaro M, Meledandri M, Fontana C, Narciso P, Nicastri E.

J Med Case Rep. 2008 Sep 30;2:315. doi: 10.1186/1752-1947-2-315.

17.

Leishmania infantum leishmaniasis in corticosteroid--treated patients.

Pittalis S, Nicastri E, Spinazzola F, Ghirga P, De Marco M, Paglia MG, Narciso P.

BMC Infect Dis. 2006 Dec 18;6:177.

18.

Application of a molecular panel to demonstrate enterotropic virus shedding by healthy and human immunodeficiency virus-infected patients.

Minosse C, Zaniratti MS, Calcaterra S, Carletti F, Muscillo M, Pisciotta M, Pillitteri L, Corpolongo A, Lauria FN, Narciso P, Anzidei G, Capobianchi MR.

J Clin Microbiol. 2005 Apr;43(4):1979-81.

19.

V gamma 9V delta 2 T-cell anergy and complementarity-determining region 3-specific depletion during paroxysm of nonendemic malaria infection.

Martini F, Paglia MG, Montesano C, Enders PJ, Gentile M, Pauza CD, Gioia C, Colizzi V, Narciso P, Pucillo LP, Poccia F.

Infect Immun. 2003 May;71(5):2945-9.

20.

P-glycoprotein expression by peripheral blood mononuclear cells from human immunodeficiency virus-infected patients is independent from response to highly active antiretroviral therapy.

Agrati C, Poccia F, Topino S, Narciso P, Selva C, Pucillo LP, D'Offizi G, Antonelli G, Bellomi F, Turriziani O, Bambacioni F.

Clin Diagn Lab Immunol. 2003 Jan;10(1):191-2. No abstract available.

Supplemental Content

Loading ...
Support Center